As a side note...
It's really annoying that Relenza is based on royalties from GSK.
Basically everyone just has to sit and speculate until GSK closes deals and confirms the "Royalty". Almost no point even hounding BTA about the details because they wouldn't be involved in the dealings.
Really hard to accurately predict the potential.
bloomberg comment, page-6
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)